| Title : Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis - Khuanjing_2021_Pharmacol.Res__105882 |
| Author(s) : Khuanjing T , Ongnok B , Maneechote C , Siri-Angkul N , Prathumsap N , Arinno A , Chunchai T , Arunsak B , Chattipakorn SC , Chattipakorn N |
| Ref : Pharmacol Res , :105882 , 2021 |
| Abstract : Khuanjing_2021_Pharmacol.Res__105882 |
| ESTHER : Khuanjing_2021_Pharmacol.Res__105882 |
| PubMedSearch : Khuanjing_2021_Pharmacol.Res__105882 |
| PubMedID: 34530122 |
Khuanjing T, Ongnok B, Maneechote C, Siri-Angkul N, Prathumsap N, Arinno A, Chunchai T, Arunsak B, Chattipakorn SC, Chattipakorn N (2021)
Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis
Pharmacol Res
:105882
Khuanjing T, Ongnok B, Maneechote C, Siri-Angkul N, Prathumsap N, Arinno A, Chunchai T, Arunsak B, Chattipakorn SC, Chattipakorn N (2021)
Pharmacol Res
:105882